Sphere Fluidics

Sphere Fluidics is a life sciences company, based in Cambridgeshire, UK and New Jersey, USA. Sphere Fluidics offers a novel platform (Cyto-Mine®) that performs single cell analysis.

Cyto-Mine® reduces costs for biopharmaceutical discovery and development. It is being adapted to single cell engineering using synthetic biology or genome editing.